Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

by Melvin Mann

Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

by Marci A. Landsmann

From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.

by Kendall K. Morgan

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman

Forward Look

New study explores impact of lowering dose due to side effects.

by Jane Langille

Forward Look

Programs aim to increase awareness of benefits.

by Sue Rochman

Forward Look

New law mandates that cancer drugs get tested in kids in clinical trials.

by Sharon Tregaskis

Forward Look

Treating prostate cancer with fewer side effects.

by Bradley Jones

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann